Clinical Utility of Real time CGM in type 2 diabetes

Clinical Utility of Real time CGM in type 2 diabetes - Clinical Utility of Real time CGM in type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025481

Enrollment

150

Registered

2016-12-31

Start date

2016-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Real time CGM(1 week) Professional CGM(1 week) Only SMBG

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Type 2 DM Patients admitted for glucose control or disease education

Exclusion criteria

Exclusion criteria: 1)Pregnancy 2)Unexpected hospitalization 3)Hospitalization within 1week 4)dementia 5)Patients judged by the investigator to be ineligible for some other reason

Design outcomes

Primary

Measure	Time frame
Patient's satisfaction for treatment	—

Secondary

Measure	Time frame
HbA1c(at 12 weeks after) Problem Areas in Diabetes Survey(PAID) status of sleep	—

Countries

Japan

Contacts

Public ContactYuya Takano

Saiseikai Yokohamashi Nanbu Hospital Department of Diabetes and Endocrinology

taka1018083@yahoo.co.jp045-832-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026